Gold prices bounce off 3-week lows; demand likely longer term
Investing.com -- Topcon reported its first quarter fiscal year 2026 results on Monday, posting sales of ¥48.5 billion, representing a 6% year-over-year decline, and an operating loss of ¥500 million.
The company’s eye care businesses maintained positive momentum, but this was offset by declining sales in its positioning segment. The operating loss was attributed to an increase in fixed costs, particularly growth investments in the eye care business.
Topcon also recorded a ¥1.5 billion extraordinary loss from money transfer damages related to a deep-fake incident at an overseas subsidiary, contributing to a ¥2.1 billion net loss for the quarter.
In the positioning segment, sales fell to ¥30.5 billion, a 10% decrease (5% excluding forex effects), with operating profit at ¥1.5 billion. While surveying equipment and GNSS sales performed well due to new product introductions, the ICT construction and IT farming businesses faced weaker demand.
The eye care segment showed growth with sales of ¥17.9 billion, up 2% (7% excluding forex effects), driven by strong performance in North America, though Europe and China showed some softening.
The company’s other segment reported an ¥800 million loss due to companywide shared R&D expenses and increased investments in new business under the eye care’s shared care strategy.
Topcon has not disclosed guidance for the full fiscal year 2026, as it plans to proceed with a previously announced tender offer at the end of July 2025, as scheduled on March 28.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.